I. Caroline LePoole, PhD | Loyola Medicine

Coronavirus 2019 (COVID-19) Update

Loyola Medicine hospitals are prepared to provide appropriate care for the safety and well-being of our community. Learn more here.

I. Caroline LePoole, PhD

Pathology

Affiliate Professor

Languages Spoken

English, Dutch

Clinical Expertise

Biography

Interests

Medical Education

Medical School
Residency
Fellowship

Board Certification

Research

  • Clinical and immunologic evaluation of three metastatic melanoma patients treated with autologous melanoma-reactive TCR-transduced T cells Moore, T.; Wagner, C. R.; Scurti, G. M.; Hutchens, K. A.; Godellas, C.; Clark, A. L.; Kolawole, E. M.; Hellman, L. M.; Singh, N. K.; Huyke, F. A.; Wang, S. Y.; Calabrese, K. M.; Embree, H. D.; Orentas, R.; Shirai, K.; Dellacecca, E.; Garrett-Mayer, E.; Li, M.; Eby, J. M.; Stiff, P. J.; Evavold, B. D.; Baker, B. M.; Le Poole, I. C.; Dropulic, B.; Clark, J. I.; Nishimura, M. I., Cancer immunology, immunotherapy : CII
  • Correction to: Clinical and immunologic evaluation of three metastatic melanoma patients treated with autologous melanoma-reactive TCR-transduced T cells Moore, T.; Wagner, C. R.; Scurti, G. M.; Hutchens, K. A.; Godellas, C.; Clark, A. L.; Kolawole, E. M.; Hellman, L. M.; Singh, N. K.; Huyke, F. A.; Wang, S. Y.; Calabrese, K. M.; Embree, H. D.; Orentas, R.; Shirai, K.; Dellacecca, E.; Garrett-Mayer, E.; Li, M.; Eby, J. M.; Stiff, P. J.; Evavold, B. D.; Baker, B. M.; Le Poole, I. C.; Dropulic, B.; Clark, J. I.; Nishimura, M. I., Cancer immunology, immunotherapy : CII
  • Alpha-N-acetyl-neuraminide alpha-2 8-sialyltransferase 1 can support immune responses toward tumors overexpressing ganglioside D3 in mice, Eby, J. M.; Barse, L.; Henning, S. W.; Rabelink, M. J.; Klarquist, J.; Gilbert, E. R.; Hammer, A. M.; Fernandez, M. F.; Yung, N.; Khan, S.; Miller, H. G.; Kessler, E. R.; Garrett-Mayer, E.; Dilling, D. F.; Hoeben, R. C.; Le Poole, I. C., Cancer immunology, immunotherapy : CII
View All ResearchShow Less
  • Ccl22 Diverts T Regulatory Cells and Controls the Growth of Melanoma Klarquist, J.; Tobin, K.; Farhangi Oskuei, P.; Henning, S. W.; Fernandez, M. F.; Dellacecca, E. R.; Navarro, F. C.; Eby, J. M.; Chatterjee, S.; Mehrotra, S.; Clark, J. I.; Le Poole, I. C., Cancer research
  • Functional cloning of a gp100-reactive T-cell receptor from vitiligo patient skin Klarquist, J.; Eby, J. M.; Henning, S. W.; Li, M.; Wainwright, D. A.; Westerhof, W.; Luiten, R. M.; Nishimura, M. I.; Le Poole, I. C., Pigment Cell & Melanoma Research
  • TNF-alpha inhibition can stabilize disease in progressive vitiligo Webb, K. C.; Tung, R.; Winterfield, L. S.; Gottlieb, A. B.; Eby, J. M.; Henning, S. W.; Le Poole, I. C., The British journal of dermatology
  • Tumour necrosis factor-alpha inhibition can stabilize disease in progressive vitiligo Webb, K. C.; Tung, R.; Winterfield, L. S.; Gottlieb, A. B.; Eby, J. M.; Henning, S. W.; Le Poole, I. C., The British journal of dermatology
  • Preferential secretion of inducible HSP70 by vitiligo melanocytes under stress Mosenson, J. A.; Flood, K.; Klarquist, J.; Eby, J. M.; Koshoffer, A.; Boissy, R. E.; Overbeck, A.; Tung, R. C.; Le Poole, I. C., Pigment Cell & Melanoma Research
  • Targeting melanocyte and melanoma stem cells by 8-hydroxy-2-dipropylaminotetralin Bonchak, J. G.; Eby, J. M.; Willenborg, K. A.; Chrobak, D.; Henning, S. W.; Krzywiec, A.; Johnson, S. L.; Le Poole, I. C., ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
  • Vitiligo treatment demystified: a flowchart for stratified treatment approaches Tung, R.; Le Poole, I. C., Experimental dermatology
  • A central role for inducible heat-shock protein 70 in autoimmune vitiligo Mosenson, J. A.; Eby, J. M.; Hernandez, C.; Le Poole, I. C., Experimental dermatology
  • Mutant HSP70 reverses autoimmune depigmentation in vitiligo Mosenson, J. A.; Zloza, A.; Nieland, J. D.; Garrett-Mayer, E.; Eby, J. M.; Huelsmann, E. J.; Kumar, P.; Denman, C. J.; Lacek, A. T.; Kohlhapp, F. J.; Alamiri, A.; Hughes, T.; Bines, S. D.; Kaufman, H. L.; Overbeck, A.; Mehrotra, S.; Hernandez, C.; Nishimura, M. I.; Guevara-Patino, J. A.; Le Poole, I. C., Science translational medicine
  • Positioning ganglioside D3 as an immunotherapeutic target in lymphangioleiomyomatosis Gilbert, E. R.; Eby, J. M.; Hammer, A. M.; Klarquist, J.; Christensen, D. G.; Barfuss, A. J.; Boissy, R. E.; Picken, M. M.; Love, R. B.; Dilling, D. F.; Le Poole, I. C., The American journal of pathology
  • Renal angiomyolipoma fat-poor variant--a clinicopathologic mimicker of malignancy, Mehta, V.; Venkataraman, G.; Antic, T.; Rubinas, T. C.; Le Poole, I. C.; Picken, M. M., Virchows Archiv : an international journal of pathology
  • A coreceptor-independent transgenic human TCR mediates anti-tumor and anti-self immunity in mice Mehrotra, S.; Al-Khami, A. A.; Klarquist, J.; Husain, S.; Naga, O.; Eby, J. M.; Murali, A. K.; Lyons, G. E.; Li, M.; Spivey, N. D.; Norell, H.; Martins da Palma, T.; Onicescu, G.; Diaz-Montero, C. M.; Garrett-Mayer, E.; Cole, D. J.; Le Poole, I. C.; Nishimura, M. I., Journal of immunology (Baltimore, Md.: 1950)
  • A current viewpoint of lymphangioleiomyomatosis supporting immunotherapeutic treatment options Dilling, D. F.; Gilbert, E. R.; Picken, M. M.; Eby, J. M.; Love, R. B.; Le Poole, I. C., American Journal of Respiratory Cell & Molecular Biology
  • Revised classification/nomenclature of vitiligo and related issues: the Vitiligo Global Issues Consensus Conference Ezzedine, K.; Lim, H. W.; Suzuki, T.; Katayama, I.; Hamzavi, I.; Lan, C. C.; Goh, B. K.; Anbar, T.; Silva de Castro, C.; Lee, A. Y.; Parsad, D.; van Geel, N.; Le Poole, I. C.; Oiso, N.; Benzekri, L.; Spritz, R.; Gauthier, Y.; Hann, S. K.; Picardo, M.; Taieb, A.; Vitiligo Global Issue Consensus Conference Panelists, Pigment Cell & Melanoma Research
  • Heme oxygenase-1 expression protects melanocytes from stress-induced cell death: implications for vitiligo. Elassiuty, Y. E.; Klarquist, J.; Speiser, J.; Yousef, R. M.; El Refaee, A. A.; Hunter, N. S.; Shaker, O. G.; Gundeti, M.; Nieuweboer-Krobotova, L.; Le Poole, I. C., Experimental dermatology
  • Notch signaling regulates mouse and human Th17 differentiation. Keerthivasan, S.; Suleiman, R.; Lawlor, R.; Roderick, J.; Bates, T.; Minter, L.; Anguita, J.; Juncadella, I.; Nickoloff, B. J.; Le Poole, I. C.; Miele, L.; Osborne, B. A., Journal of Immunology
  • Topical application of bleaching phenols; in-vivo studies and mechanism of action relevant to melanoma treatment. Hariharan, V.; Toole, T.; Klarquist, J.; Mosenson, J.; Longley, B. J.; Le Poole, I. C., Melanoma research
  • Functional alterations in protein kinase C beta II expression in melanoma. Voris, J. P.; Sitailo, L. A.; Rahn, H. R.; Defnet, A.; Gerds, A. T.; Sprague, R.; Yadav, V.; Le Poole, I. C.; Denning, M. F., Pigment Cell & Melanoma Research
  • Monobenzyl ether of hydroquinone and 4-tertiary butyl phenol activate markedly different physiological responses in melanocytes: relevance to skin depigmentation. Hariharan, V.; Klarquist, J.; Reust, M. J.; Koshoffer, A.; McKee, M. D.; Boissy, R. E.; Le Poole, I. C., Journal of Investigative Dermatology
  • Reduced skin homing by functional Treg in vitiligo Klarquist, J.; Denman, C. J.; Hernandez, C.; Wainwright, D. A.; Strickland, F. M.; Overbeck, A.; Mehrotra, S.; Nishimura, M. I.; Le Poole, I. C., Pigment Cell & Melanoma Research
  • De-N-acetyl GM3 promotes melanoma cell migration and invasion through urokinase plasminogen activator receptor signaling-dependent MMP-2 activation Liu, J. W.; Sun, P.; Yan, Q.; Paller, A. S.; Gerami, P.; Ho, N.; Vashi, N.; Le Poole, I. C.; Wang, X. Q., Cancer research
  • Melanoma-associated antigen expression in lymphangioleiomyomatosis renders tumor cells susceptible to cytotoxic T cells. Klarquist, J.; Barfuss, A.; Kandala, S.; Reust, M. J.; Braun, R. K.; Hu, J.; Dilling, D. F.; McKee, M. D.; Boissy, R. E.; Love, R. B.; Nishimura, M. I.; Le Poole, I. C., American Journal of Pathology
  • Relationship between CD8-dependent antigen recognition T cell functional avidity, and tumor cell recognition, Moore, T. V.; Lyons, G. E.; Brasic, N.; Roszkowski, J. J.; Voelkl, S.; Mackensen, A.; Kast, W. M.; Le Poole, I. C.; Nishimura, M. I., Cancer immunology, immunotherapy : CII
  • Autoimmune etiology of generalized vitiligo Le Poole, I. C.; Luiten, R. M., Current directions in autoimmunity
  • HSP70i accelerates depigmentation in a mouse model of autoimmune vitiligo. Denman, C. J.; McCracken, J.; Hariharan, V.; Klarquist, J.; Oyarbide-Valencia, K.; Guevara-Patino, J. A.; Le Poole, I. C., Journal of Investigative Dermatology
  • Immortalization of human melanocytes does not alter the de novo properties of nitric oxide to induce cell detachment from extracellular matrix components via cGMP Ivanova, K.; Lambers, B.; van den Wijngaard, R.; Le Poole, I. C.; Grigorieva, O.; Gerzer, R.; Das, P. K., In vitro cellular & developmental biology.Animal
  • Langerhans cells and dendritic cells are cytotoxic towards HPV16 E6 and E7 expressing target cells. Le Poole, I. C.; ElMasri, W. M.; Denman, C. J.; Kroll, T. M.; Bommiasamy, H.; Lyons Eiben, G.; Kast, W. M., Cancer Immunology, Immunotherapy
  • Vitiligo pathogenesis: autoimmune disease genetic defect, excessive reactive oxygen species, calcium imbalance, or what else?, Schallreuter, K. U.; Bahadoran, P.; Picardo, M.; Slominski, A.; Elassiuty, Y. E.; Kemp, E. H.; Giachino, C.; Liu, J. B.; Luiten, R. M.; Lambe, T.; Le Poole, I. C.; Dammak, I.; Onay, H.; Zmijewski, M. A.; Dell'Anna, M. L.; Zeegers, M. P.; Cornall, R. J.; Paus, R.; Ortonne, J. P.; Westerhof, W., Experimental dermatology
  • T-cell avidity and tuning: the flexible connection between tolerance and autoimmunity van den Boorn, J. G.; Le Poole, I. C.; Luiten, R. M., International reviews of immunology
  • Therapeutic implications of autoimmune vitiligo T cells Oyarbide-Valencia, K.; van den Boorn, J. G.; Denman, C. J.; Li, M.; Carlson, J. M.; Hernandez, C.; Nishimura, M. I.; Das, P. K.; Luiten, R. M.; Le Poole, I. C., Autoimmunity Reviews
  • 4-Tertiary butyl phenol exposure sensitizes human melanocytes to dendritic cell-mediated killing: relevance to vitiligo. Kroll, T. M.; Bommiasamy, H.; Boissy, R. E.; Hernandez, C.; Nickoloff, B. J.; Mestril, R.; Le Poole, I. C., Journal of Investigative Dermatology
  • Antitumor efficacy of Venezuelan equine encephalitis virus replicon particles encoding mutated HPV16 E6 and E7 genes Cassetti, M. C.; McElhiney, S. P.; Shahabi, V.; Pullen, J. K.; Le Poole, I. C.; Eiben, G. L.; Smith, L. R.; Kast, W. M., Vaccine
  • Autoimmune aspects of depigmentation in vitiligo Le Poole, I. C.; Wankowicz-Kalinska, A.; van den Wijngaard, R. M.; Nickoloff, B. J.; Das, P. K., Journal of Investigative Dermatology.Symposium Proceedings
  • Expression of gp100 and CDK2 in melanoma cells is not co-regulated by a shared promoter region. Stennett, L. S.; Riker, A. I.; Kroll, T. M.; Chamberlin, J.; Miki, T.; Nickoloff, B. J.; Le Poole, I. C., Pigment Cell Research
  • Advances in prophylactic cancer vaccine research Le Poole, I. C.; Bommiasamy, H.; Bocchetta, M.; Kast, W. M., Expert Review of Anticancer Therapy
  • Cervical cancer vaccines: recent advances in HPV research Eiben, G. L.; da Silva, D. M.; Fausch, S. C.; Le Poole, I. C.; Nishimura, M. I.; Kast, W. M., Viral immunology
  • Expansion of vitiligo lesions is associated with reduced epidermal CDw60 expression and increased expression of HLA-DR in perilesional skin. Le Poole, I. C.; Stennett, L. S.; Bonish, B. K.; Dee, L.; Robinson, J. K.; Hernandez, C.; Hann, S. K.; Nickoloff, B. J., British Journal of Dermatology
  • HPV protein/peptide vaccines: from animal models to clinical trials Fausch, S. C.; Da Silva, D. M.; Eiben, G. L.; Le Poole, I. C.; Kast, W. M., Frontiers in bioscience : a journal and virtual library
  • Recent progress in tumour vaccine development Le Poole, I. C.; Bommiasamy, H.; Kast, W. M., Expert opinion on investigational drugs
  • Emerging strategies in tumor vaccines Le Poole, I. C.; Gerberi, M. A.; Kast, W. M., Current opinion in oncology
  • Interferon-gamma reduces melanosomal antigen expression and recognition of melanoma cells by cytotoxic T cells Le Poole, I. C.; Riker, A. I.; Quevedo, M. E.; Stennett, L. S.; Wang, E.; Marincola, F. M.; Kast, W. M.; Robinson, J. K.; Nickoloff, B. J., The American journal of pathology
  • 'VIT1' a novel gene associated with vitiligo, Le Poole, I. C.; Sarangarajan, R.; Zhao, Y.; Stennett, L. S.; Brown, T. L.; Sheth, P.; Miki, T.; Boissy, R. E., Pigment Cell Research / sponsored by the European Society for Pigment Cell Research and the International Pigment Cell Society
  • A symbiotic concept of autoimmunity and tumour immunity: lessons from vitiligo Das, P. K.; van den Wijngaard, R. M.; Wankowicz-Kalinska, A.; Le Poole, I. C., Trends in immunology
  • Inhibition of melanosome transfer from melanocytes to keratinocytes by lectins and neoglycoproteins in an in vitro model system Minwalla, L.; Zhao, Y.; Cornelius, J.; Babcock, G. F.; Wickett, R. R.; Le Poole, I. C.; Boissy, R. E., Pigment Cell Research / sponsored by the European Society for Pigment Cell Research and the International Pigment Cell Society
  • Keratinocytes play a role in regulating distribution patterns of recipient melanosomes in vitro Minwalla, L.; Zhao, Y.; Le Poole, I. C.; Wickett, R. R.; Boissy, R. E., The Journal of investigative dermatology
  • Expression and modulation of apoptosis regulatory molecules in human melanocytes: significance in vitiligo van den Wijngaard, R. M.; Aten, J.; Scheepmaker, A.; Le Poole, I. C.; Tigges, A. J.; Westerhof, W.; Das, P. K., The British journal of dermatology
  • Micro-anatomy related antigen expression in melanocytic lesions Meije, C. B.; Mooi, W. J.; Le Poole, I. C.; Van Muijen, G. N.; Das, P. K., The Journal of pathology
  • PIG3V an immortalized human vitiligo melanocyte cell line, expresses dilated endoplasmic reticulum, Le Poole, I. C.; Boissy, R. E.; Sarangarajan, R.; Chen, J.; Forristal, J. J.; Sheth, P.; Westerhof, W.; Babcock, G.; Das, P. K.; Saelinger, C. B., In vitro cellular & developmental biology.Animal
  • The cytotoxicity and apoptosis induced by 4-tertiary butylphenol in human melanocytes are independent of tyrosinase activity Yang, F.; Sarangarajan, R.; Le Poole, I. C.; Medrano, E. E.; Boissy, R. E., The Journal of investigative dermatology